Report: Cost of MRSA tops €23m annually

A new report to be launched today estimates that MRSA infection in Irish hospitals costs in excess of €23m annually.

The report, entitiled “Meticillin-Resistant Staphylococcus aureas (MRSA) in Ireland: Addressing the Issues”, was developed by a multidisciplinary advisory group including microbiologists, hospital pharmacists and patient advocates and funded by an unrestricted educational grant from Pfizer.